. 2010 Jan 20;2010(1):CD003228. doi:10.1002/14651858.CD003228.pub2
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Dake 2007.
| Trial name or title | Evaluation of the Zilver PTX drug‐eluting stent in the above‐the‐knee femoropopliteal artery. |
| Methods | Randomised, open label. |
| Participants | Phase 1 enrolling patients with lesions less than 7 cm long. Phase 2 of the trial will include longer lesions (up to 14 cm long). |
| Interventions | Zilver® PTX™ drug‐eluting vascular stent or angioplasty. |
| Outcomes | Event‐free survival rate and the patency rate at 6 and 12‐month follow up. |
| Starting date | March 2005 |
| Contact information | |
| Notes | NCT00120406 William Cook Europe MED Institute, Incorporated Cook Japan Incorporated. Estimated completion date November 2013 |